224 — South Bend, Indiana

224 is a clinical research site located in South Bend, Indiana, United States.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

224 has participated in 2 clinical trials.

Therapeutic areas: Rheumatoid Arthritis.

Sponsors: UCB Pharma SA, UCB Pharma.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 224?

224 has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 224 conducted?

224 has 2 clinical trials on record. Their work covers Rheumatoid Arthritis.

Is 224 accredited by Crixeo Health?

224 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 224?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.